Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme

被引:283
作者
Lee, Thomas J. W. [1 ,2 ,3 ]
Rutter, Matthew D. [2 ,3 ,4 ]
Blanks, Roger G. [5 ]
Moss, Sue M. [6 ]
Goddard, Andrew F. [7 ]
Chilton, Andrew [8 ]
Nickerson, Claire [9 ]
McNally, Richard J. Q.
Patnick, Julietta [9 ]
Rees, Colin J. [3 ,4 ,10 ]
机构
[1] Newcastle Univ, Royal Victoria Infirm, Inst Hlth & Soc, Sir James Spence Inst, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[2] Univ Hosp N Tees, Stockton On Tees, England
[3] S Tyneside Dist Hosp, NREG, S Shields, Tyne & Wear, England
[4] Univ Durham, Stockton On Tees, England
[5] Canc Epidemiol Unit, Oxford, England
[6] Univ London, Inst Canc Res, Canc Screening Evaluat Unit, London, England
[7] Derby City Gen Hosp, Derbyshire Bowel Canc Screening Ctr, Derby, England
[8] Gen Hosp Kettering, Northants & Rutland Bowel Canc Screening Ctr, Kettering, England
[9] NHS Canc Screening Programmes, Sheffield, S Yorkshire, England
[10] S Tyneside Gen Hosp, S Tyne Bowel Canc Screening Ctr, S Shields, England
基金
英国医学研究理事会;
关键词
COLORECTAL-CANCER; UK; PILOT; RISK;
D O I
10.1136/gutjnl-2011-300651
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Objectives Colonoscopy is central to colorectal cancer (CRC) screening. Success of CRC screening is dependent on colonoscopy quality. The NHS Bowel Cancer Screening Programme (BCSP) offers biennial faecal occult blood (FOB) testing to 60-74 year olds and colonoscopy to those with positive FOB tests. All colonoscopists in the screening programme are required to meet predetermined standards before starting screening and are subject to ongoing quality assurance. In this study, the authors examine the quality of colonoscopy in the NHS BCSP and describe new and established measures to assess and maintain quality. Design The NHS BCSP database collects detailed data on all screening colonoscopies. Prospectively collected data from the first 3 years of the programme (August 2006 to August 2009) were analysed. Colonoscopy quality indicators (adenoma detection rate (ADR), polyp detection rate, colonoscopy withdrawal time, caecal intubation rate, rectal retroversion rate, polyp retrieval rate, mean sedation doses, patient comfort scores, bowel preparation quality and adverse event incidence) were calculated along with measures of total adenoma detection. Results 2 269 983 individuals returned FOB tests leading to 36 460 colonoscopies. Mean unadjusted caecal intubation rate was 95.2%, and mean withdrawal time for normal procedures was 9.2 min. The mean ADR per colonoscopist was 46.5%. The mean number of adenomas per procedure (MAP) was 0.91; the mean number of adenomas per positive procedure (MAP+) was 1.94. Perforation occurred after 0.09% of procedures. There were no procedure-related deaths. Conclusions The NHS BCSP provides high-quality colonoscopy, as demonstrated by high caecal intubation rate, ADR and comfort scores, and low adverse event rates. Quality is achieved by ensuring BCSP colonoscopists meet a high standard before starting screening and through ongoing quality assurance. Measuring total adenoma detection (MAP and MAP+) as adjuncts to ADR may further enhance quality assurance.
引用
收藏
页码:1050 / 1057
页数:8
相关论文
共 24 条
[1]
Wide variation in adenoma detection rates at screening flexible sigmoidoscopy [J].
Atkin, W ;
Rogers, P ;
Cardwell, C ;
Cook, C ;
Cuzick, J ;
Wardle, J ;
Edwards, R .
GASTROENTEROLOGY, 2004, 126 (05) :1247-1256
[2]
Bell GD, 1991, GUT, V32, P725
[3]
Colorectal cancer screening: A comparison of 35 initiatives in 17 countries [J].
Benson, Victoria S. ;
Patnick, Julietta ;
Davies, Anna K. ;
Nadel, Marion R. ;
Smith, Robert A. ;
Atkin, Wendy S. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (06) :1357-1367
[4]
A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? [J].
Bowles, CJA ;
Leicester, R ;
Romaya, C ;
Swarbrick, E ;
Williams, CB ;
Epstein, O .
GUT, 2004, 53 (02) :277-283
[5]
Variations between endoscopists in rates of detection of colorectal neoplasia and their impact on a regional screening program based on colonoscopy after fecal occult blood testing [J].
Bretagne, Jean-Francois ;
Hamonic, Stephanie ;
Piette, Christine ;
Manfredi, Sylvain ;
Leray, Emmanuelle ;
Durand, Gerard ;
Riou, Francoise .
GASTROINTESTINAL ENDOSCOPY, 2010, 71 (02) :335-341
[6]
Chilton A, 2011, BCSP QUALITY ASSURAN
[7]
A lexicon for endoscopic adverse events: report of an ASGE workshop [J].
Cotton, Peter B. ;
Eisen, Glenn M. ;
Aabakken, Lars ;
Baron, Todd H. ;
Hutter, Matt M. ;
Jacobson, Brian C. ;
Mergener, Klaus ;
Nemcek, Albert, Jr. ;
Petersen, Bret T. ;
Petrini, John L. ;
Pike, Irving M. ;
Rabeneck, Linda ;
Romagnuolo, Joseph ;
Vargo, John J. .
GASTROINTESTINAL ENDOSCOPY, 2010, 71 (03) :446-454
[8]
Process quality and incidence of acute complications in a series of more than 230 000 outpatient colonoscopies [J].
Crispin, A. ;
Birkner, B. ;
Munte, A. ;
Nusko, G. ;
Mansmann, U. .
ENDOSCOPY, 2009, 41 (12) :1018-1025
[9]
Impact of a national external quality assessment scheme for breast pathology in the UK [J].
Ellis, IO ;
Coleman, D ;
Wells, C ;
Kodikara, S ;
Paish, EM ;
Moss, S ;
Al-Sam, S ;
Anderson, N ;
Bobrow, L ;
Buley, I ;
Connolly, CE ;
Dallimore, NS ;
Hales, S ;
Hanby, A ;
Humphreys, S ;
Knox, F ;
Lowe, J ;
Macartney, J ;
Nash, R ;
Parham, D ;
Patnick, J ;
Pinder, SE ;
Quinn, CM ;
Robertson, AJ ;
Shrimankar, J ;
Walker, RA ;
Winder, R .
JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (02) :138-145
[10]
JAG, DOPS FORMS